Delivery Order SPE2DB22D2206-SPE2DB24FGE72
Award Date 3/20/24
Potential Completion Date 4/10/24
Potential Value $6.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $10,358.80 order is for the supply of Mekinist 0.5 mg tablets in support of military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Mekinist 0.5 mg tablet. The contract has a firm fixed price of $8,552.49 and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,341.02, is for the supply of Mekinist 2 mg tablets to support federal healthcare programs. The contract is a firm fixed-price delivery order with a period of performance through February 27, 2025. It was awarded on February 5, 2025 and does not have a set-aside designation, indicating open...
- The Defense Logistics Agency awarded a $4,701.12 delivery order to AmerisourceBergen Drug Corp for Mekinist 0.05 mg/ml solution (90ml) on December 30, 2025, with an ultimate completion date of January 22, 2026. This is a firm fixed price, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,401.49 to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on November 14, 2025, with completion targeted for December 8, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $12,017.36 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Mekinist 0.5 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 14, 2026. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Mekinist 2 mg tablets (30-count units) with a ceiling value of $10,191.22. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,191.22 for 30 tablets of Mekinist 2 mg on December 23, 2025, with an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement of the oncology medication and contains no subcontractor information. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $8,226.96 delivery order to AmerisourceBergen Drug Corp for Mekinist 0.05 mg/ml solution (90 ml), an oncology medication used in cancer treatment. This non-set-aside, firm fixed-price delivery order was awarded on November 28, 2025, with an ultimate completion date of December 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $16,303.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mekinist 0.5 mg tablets (30-count units) on December 12, 2025, with completion targeted for January 6, 2026. The award, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This child contract fulfills pharmaceutical supply requirements for...